Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epiduo and Cetaphil Regimen in Student Athletes with Acne
NCT02249104Phase 4Completed
- Sponsor
- Galderma
- Start
- Aug 2014
- Primary completion
- Feb 2015
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adapalene + benzoyl peroxide in acne vulgaris, sponsored by Galderma. Primary endpoint: Mean Change From Baseline in Total Lesion Count at 8 weeks. Started Aug 2014; status: completed.
02
Drugs
adapalene + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02249104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02249104.